Condensed Consolidated Statements of Income - Unaudited - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Revenues: | ||||
| Direct premiums | $ 866,254 | $ 845,358 | $ 1,725,099 | $ 1,686,404 |
| Ceded premiums | (433,408) | (427,561) | (843,930) | (837,325) |
| Net premiums | 432,846 | 417,797 | 881,169 | 849,079 |
| Commissions and fees | 306,032 | 268,193 | 602,988 | 517,138 |
| Investment income net of investment expenses | 55,549 | 54,111 | 111,888 | 107,702 |
| Interest expense on surplus note | (14,621) | (15,659) | (29,289) | (31,444) |
| Net investment income | 40,928 | 38,452 | 82,599 | 76,258 |
| Realized investment gains (losses) | (2,338) | 565 | (2,421) | 572 |
| Other investment gains (losses) | (528) | (664) | 312 | 634 |
| Investment gains (losses) | (2,866) | (99) | (2,109) | 1,206 |
| Other, net | 16,394 | 66,612 | 33,530 | 83,223 |
| Total revenues | 793,334 | 790,955 | 1,598,177 | 1,526,904 |
| Benefits and expenses: | ||||
| Benefits and claims | 152,494 | 150,030 | 327,355 | 316,351 |
| Future policy benefits remeasurement (gain) loss | (5,895) | (4,329) | (9,168) | (4,275) |
| Amortization of deferred policy acquisition costs | 80,043 | 73,643 | 158,592 | 145,692 |
| Sales commissions | 166,291 | 142,154 | 324,409 | 273,292 |
| Insurance expenses | 64,362 | 62,685 | 129,168 | 125,834 |
| Insurance commissions | 5,751 | 7,399 | 11,875 | 17,033 |
| Interest expense | 6,000 | 6,099 | 12,005 | 12,870 |
| Other operating expenses | 89,791 | 80,505 | 188,129 | 173,950 |
| Total benefits and expenses | 558,837 | 518,186 | 1,142,365 | 1,060,747 |
| Income from continuing operations before income taxes | 234,497 | 272,769 | 455,812 | 466,157 |
| Income taxes from continuing operations | 56,153 | 63,467 | 108,417 | 108,442 |
| Income from continuing operations | 178,344 | 209,302 | 347,395 | 357,715 |
| Loss from discontinued operations, net of income taxes | 0 | (208,131) | 0 | (218,641) |
| Net income | $ 178,344 | $ 1,171 | $ 347,395 | $ 139,074 |
| Basic earnings per share: | ||||
| Continuing operations | $ 5.41 | $ 6.08 | $ 10.47 | $ 10.30 |
| Discontinued operations | 0 | (6.05) | 0 | (6.30) |
| Basic earnings per share | 5.41 | 0.03 | 10.47 | 4.00 |
| Diluted earnings per share: | ||||
| Continuing operations | 5.40 | 6.07 | 10.45 | 10.28 |
| Discontinued operations | 0 | (6.04) | 0 | (6.29) |
| Diluted earnings per share | $ 5.40 | $ 0.03 | $ 10.45 | $ 3.99 |
| Weighted-average shares used in computing earnings per share: | ||||
| Basic | 32,870 | 34,383 | 33,080 | 34,633 |
| Diluted | 32,911 | 34,440 | 33,126 | 34,688 |
| X | ||||||||||
- Definition Earnings per share basic and diluted other disclosure. No definition available.
|
| X | ||||||||||
- Definition Interest expense on surplus note. No definition available.
|
| X | ||||||||||
- Definition Investment income net of investment expenses. No definition available.
|
| X | ||||||||||
- Definition Other investment gains (losses). No definition available.
|
| X | ||||||||||
- Definition The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of written premiums ceded to other entities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of amortization expense (reversal of expense) for deferred policy acquisition costs. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums written. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The expense incurred by an insurance company to persons or entities for generating or placing insurance or investment contracts with the company, usually determined as a percentage of policy or contract premiums. Excludes advances or draws to be applied against commissions earned. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of fees and commissions from banking, advisory, brokerage, and securities underwriting activities. Activities include, but are not limited to, underwriting securities, private placements of securities, investment advisory and management services, merger and acquisition services, sale and servicing of mutual funds, and other related consulting fees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of remeasurement gain (loss) on liability for future policy benefit from application of revised benefit ratio as of contract issue. Includes, but is not limited to, remeasurement gain (loss) for annuitization insurance benefit, death and other insurance benefits, and traditional and limited-payment contracts. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums written. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|